Skip to main content

Table 4 Separate associations between hospital quality system development and outcomes for patient safety themes

From: The association between quality system development stage and the implementation of process-level patient safety themes in Dutch hospitals: an observational study

 

Model 1

Quality system (overall)

1: Policy and strategy

2: Human resource management

3: Patient involvement

4: Practice guidelines

5: Systematic quality improvement

Outcome

Estimate (SE)

R2

Estimate (SE)

R2

Estimate (SE)

R2

Estimate (SE)

R2

Estimate (SE)

R2

Estimate (SE)

R2

Time-out procedure

−1.89 (0.82)

32.3

− 1.33 (0.66)

25.4

− 1.25 (0.89)

11.4

−0.16 (0.38)

0.9

−1.08 (0.74)

13.7

−0.57 (0.37)

14.7

 - Check patient

−2.49 (1.13)

43.5

−1.65 (0.88)

36.2

−0.73 (0.40)

36.0

0.19 (0.51)

6.1

 - Check procedure

−2.61 (1.37)

18.3

−1.46 (1.06)

9.6

−1.78 (1.48)

5.2

−0.18 (0.58)

−1.2

−1.02 (1.13)

3.3

−1.02 (0.55)

16.8

 - Check side/site

−0.96 (0.49)

40.8

−0.32 (0.44)

8.8

−0.40 (0.54)

8.8

−0.59 (0.14)

8.5

0.09 (0.46)

−0.5

−0.02 (0.23)

1.0

 - Focus during TOP

−0.75 (0.62)

8.8

−0.45 (0.50)

4.8

−0.28 (0.61)

−0.1

− 0.39 (0.24)

15.8

− 0.08 (0.53)

−1.9

−0.02 (0.27)

−1.7

Contrast- induced nephropathy

0.86 (0.68)

0.11

0.29 (0.44)**

14.0

−0.08 (0.63)

−0.9

0.55 (0.25)*

30.8

−0.11 (0.45)

−1.7

−0.17 (0.29)

2.2

Pain process indicator 100%

0.09 (0.98)

−0.5

−0.55 (0.75)

2.3

0.41 (0.89)

0.1

0.28 (0.37)

7.3

−0.66 (0.62)

5.8

0.12 (0.40)

−0.2

Medication reconciliation on admission

0.64 (1.40)

−1.3

0.53 (0.99)

−0.9

0.42 (1.06)

−5.5

0.97 (0.76)

8.4

−0.41 (1.00)

−3.8

−0.13 (0.67)

−7.5

Medication reconciliation at discharge

1.01 (1.30)

6.3

1.73 (0.87)*

26.0

−0.64 (0.87)

5.0

−0.002 (0.74)

−0.8

1.33 (0.92)

16.6

0.21 (0.59)

3.1

High-Risk Medication

0.51 (0.91)

2.4

−0.04 (0.68)

−1.2

−0.81 (0.61)

12.0

0.89 (0.42)*

28.4

0.20 (0.66)

0.1

0.20 (0.45)

−0.1

  1. * p < 0.10, **p < 0.05